Paper41599115
Targeting Redox Homeostasis and Cell Survival Signaling with a Flavonoid-Rich Extract of Bergamot Juice in In Vitro and In Vivo Colorectal Cancer Models.
Maugeri A and 5 others. Pharmaceutics, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Targeting Redox Homeostasis and Cell Survival Signaling with a Flavonoid-Rich Extract of Bergamot Juice in In Vitro and In Vivo Colorectal Cancer Models. Papers, record 41599115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599115
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting Redox Homeostasis and Cell Survival Signaling with a Flavonoid-Rich Extract of Bergamot Juice in In Vitro and In Vivo Colorectal Cancer Models.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35770398 | Citrus Flavonoids and Autoimmune Diseases: A Systematic Review of Clinical Studies. | Curr Med Chem | 2023 | https://conductscience.org/library/papers/35770398 | PubMed |
| 2 | 39389472 | (Poly)phenol-rich grape and blueberry extract prevents LPS-induced disruption of the blood-brain barrier through the modulation of the gut microbiota-derived uremic toxins. | Neurochem Int | 2024 | https://conductscience.org/library/papers/39389472 | PubMed |
| 3 | 29243303 | Genotoxic and mutagenic properties of Ni and NiO nanoparticles investigated by comet assay, γ-H2AX staining, Hprt mutation assay and ToxTracker reporter cell lines. | Environ Mol Mutagen | 2018 | https://conductscience.org/library/papers/29243303 | PubMed |
| 4 | 37298797 | Mechanisms of Action of Fruit and Vegetable Phytochemicals in Colorectal Cancer Prevention. | Molecules | 2023 | https://conductscience.org/library/papers/37298797 | PubMed |
| 5 | 32346444 | Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway. | Exp Ther Med | 2020 | https://conductscience.org/library/papers/32346444 | PubMed |
| 6 | 25575572 | Nutrients, foods, and colorectal cancer prevention. | Gastroenterology | 2015 | https://conductscience.org/library/papers/25575572 | PubMed |
| 7 | 24868862 | Evaluation of bioactive components and antioxidant and anticancer properties of citrus wastes generated during bioethanol production. | Nat Prod Commun | 2014 | https://conductscience.org/library/papers/24868862 | PubMed |
| 8 | 30919084 | A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apcam1137). | Eur J Nutr | 2020 | https://conductscience.org/library/papers/30919084 | PubMed |
| 9 | 26764233 | NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells. | Life Sci | 2016 | https://conductscience.org/library/papers/26764233 | PubMed |
| 10 | 26797111 | Naringenin-Mediated ATF3 Expression Contributes to Apoptosis in Human Colon Cancer. | Biomol Ther (Seoul) | 2016 | https://conductscience.org/library/papers/26797111 | PubMed |
| 11 | 40722718 | Colorectal Cancer: Therapeutic Approaches and Their Complications. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722718 | PubMed |
| 12 | 33529754 | Citrus fruit intake and lung cancer risk: A meta-analysis of observational studies. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33529754 | PubMed |
| 13 | 17064697 | Oxidative stress induces H2AX phosphorylation in human spermatozoa. | FEBS Lett | 2006 | https://conductscience.org/library/papers/17064697 | PubMed |
| 14 | 31641109 | MLH1 deficiency leads to deregulated mitochondrial metabolism. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31641109 | PubMed |
| 15 | 15113710 | Polyphenols: food sources and bioavailability. | Am J Clin Nutr | 2004 | https://conductscience.org/library/papers/15113710 | PubMed |
| 16 | 28214209 | Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer. | Pathol Res Pract | 2017 | https://conductscience.org/library/papers/28214209 | PubMed |
| 17 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 18 | 22814742 | Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate. | J Cancer Res Clin Oncol | 2012 | https://conductscience.org/library/papers/22814742 | PubMed |
| 19 | 30597838 | Flavonoids in Cancer and Apoptosis. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30597838 | PubMed |
| 20 | 31575057 | The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31575057 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41599115
GET https://conductscience.org/api/papers/v1/41599115/references?page=2